Toll-like receptor 9 agonists as cancer therapeutics

被引：53
|
作者：
Holtick, Udo [1 ,2 ]
Scheulen, Max E. [3 ]
von Bergwelt-Baildon, Michael S. [1 ,2 ]
Weihrauch, Martin R. [1 ,2 ]
机构：
[1] Univ Cologne, Dept Internal Med 1, D-50924 Cologne, Germany
[2] Univ Cologne, Lab Transplantat & Tumor Immunol, Max Eder Grp, D-50924 Cologne, Germany
[3] Univ Essen Gesamthsch, W German Canc Ctr, Dept Med Canc Res, Essen, Germany
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2011年 / 20卷 / 03期
关键词：
cancer; immunotherapy; TLR9; agonists; vaccine; BACTERIAL CPG-DNA; PHASE-II TRIAL; NF-KAPPA-B; T-CELLS; IMMUNOSTIMULATORY ACTIVITY; DENDRITIC CELLS; MOLECULAR-PATTERNS; ANTITUMOR-ACTIVITY; INNATE IMMUNITY; GROWTH-FACTOR;
D O I：
10.1517/13543784.2011.553187
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Areas covered: This review summarizes TLR9 signaling and the impact of TLR9 agonists on the immune response. The most recent experimental and clinical data are analyzed as well as the development of new TLR9 agonists in current clinical trials. Expert opinion: Application of TLR9 agonists, in particular, combination strategies with chemo- or radiotherapy seem a promising and efficient immunotherapeutic approach in cancer patients even with refractory disease. Simultaneous application of TLR9 agonists aims at supporting the patient's immune response and overcoming specific immunosuppressant strategies developed by tumors. Combinatory approaches of the future might also seek for synergism of TLR9 agonists with other immunomodulatory strategies such as B-cell activation using the CD40--CD40L system.
引用
收藏
页码：361 / 372
页数：12
相关论文
共 50 条
  • [31] Analysis of Toll-like receptor 7 and Toll-like receptor 9 chimeric molecules
    Willemsen, J.
    Yu, P.
    Bauer, S.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 35 - 35
  • [32] Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy
    Iribarren, Kristina
    Bloy, Norma
    Buque, Aitziber
    Cremer, Isabelle
    Eggermont, Alexander
    Fridman, Wolf Herve
    Fucikova, Jitka
    Galon, Jerome
    Spisek, Radek
    Zitvogel, Laurence
    Kroemer, Guido
    Galluzzi, Lorenzo
    ONCOIMMUNOLOGY, 2016, 5 (03):
  • [33] Bibliometric analysis of toll-like receptor agonists associated with cancer therapy
    Li, Wei
    Wan, Li
    Duan, Shaojun
    Xu, Jingjing
    MEDICINE, 2022, 101 (01) : E28520
  • [34] The Biology of Toll-Like Receptor 9 and Its Role in Cancer
    Alzahrani, Badr
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2020, 30 (05): : 457 - 474
  • [35] Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics
    Kaur, Arshpreet
    Baldwin, Jeremy
    Brar, Deshkanwar
    Salunke, Deepak B.
    Petrovsky, Nikolai
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2022, 70
  • [36] New developments in Toll-like receptor targeted therapeutics
    Connolly, Dympna J.
    O'Neill, Luke A. J.
    CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (04) : 510 - 518
  • [37] Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice
    Gao, Wenyan
    Sun, Xiaodan
    Li, Danni
    Sun, Lin
    He, Yang
    Wei, Huanping
    Jin, Feng
    Cao, Yaming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 89
  • [38] Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
    Rolfo, Christian
    Giovannetti, Elisa
    Martinez, Pablo
    McCue, Shannon
    Naing, Aung
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [39] Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
    Kirtland, Max E.
    Tsitoura, Daphne C.
    Durham, Stephen R.
    Shamji, Mohamed H.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [40] Toll-Like Receptor-2/6 and Toll-Like Receptor-9 Agonists Suppress Viral Replication but Not Airway Hyperreactivity in Guinea Pigs
    Drake, Matthew G.
    Evans, Scott E.
    Dickey, Burton F.
    Fryer, Allison D.
    Jacoby, David B.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2013, 48 (06) : 790 - 796
12345